Cart
sales@molnova.com
Elotuzumab
CAS No. 915296-00-3
Elotuzumab( —— )
Catalog No. M34757 CAS No. 915296-00-3
Elotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 360 | In Stock |
|
| 5MG | 655 | In Stock |
|
| 10MG | 924 | In Stock |
|
| 25MG | 1359 | In Stock |
|
| 50MG | 1795 | In Stock |
|
| 100MG | 2446 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameElotuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionElotuzumab(HuLuc 63) is a monoclonal antibody that targets the SLAMF7 receptor.
-
DescriptionElotuzumab is a monoclonal antibody directed against the SLAMF7 receptor. Elotuzumab has no significant antimyeloma activity when given as a single agent with relapsed or refractory multiple myeloma (RRMM). Elotuzumab results in improved response and outcome when combined with other antimyeloma agents.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number915296-00-3
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Magen H, et al. Elotuzumab: the first approved monoclonal antibody for multiple myeloma treatment. Ther Adv Hematol. 2016;7(4):187-195.
molnova catalog
related products
-
1-Methoxyphaseollidi...
1-Methoxyphaseollidin exhibits anti-Helicobacter pylori activity against the CLAR and AMOX-resistant strain as well as four CLAR (AMOX)-sensitive strains.
-
Glucobrassicanapin
The seeds of Lepidium apetalum.
-
RPR107393 free base
RPR107393 free base is a selective inhibitor of squalene synthase [rat liver microsomal squalene synthase] with an IC50 of 0.8 nM.
